Ronald F Pfeiffer

Summary

Affiliation: University of Tennessee
Country: USA

Publications

  1. ncbi Potential of transdermal drug delivery in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis 38163, USA
    Drugs Aging 19:561-70. 2002
  2. doi Autonomic dysfunction in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Memphis, TN 38163, USA
    Expert Rev Neurother 12:697-706. 2012
  3. pmc High-throughput mutational analysis of TOR1A in primary dystonia
    Jianfeng Xiao
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA
    BMC Med Genet 10:24. 2009
  4. doi Neurologic presentations of gastrointestinal disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Memphis, TN 38163, USA
    Neurol Clin 28:75-87. 2010
  5. doi Non-motor parkinsonism
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, TN, USA
    Parkinsonism Relat Disord 13:S211-20. 2007
  6. doi Wilson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA
    Handb Clin Neurol 100:681-709. 2011
  7. doi Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
    Mov Disord 25:S94-7. 2010
  8. ncbi Gastrointestinal dysfunction in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA
    Lancet Neurol 2:107-16. 2003
  9. doi Impaired leg extensor strength in individuals with Parkinson disease and relatedness to functional mobility
    Brian K Schilling
    Exercise Neuromechanics Laboratory, The University of Memphis, 314 Elma Neal Roane Fieldhouse, Memphis, TN 38152 3480, USA
    Parkinsonism Relat Disord 15:776-80. 2009
  10. pmc Effects of moderate-volume, high-load lower-body resistance training on strength and function in persons with Parkinson's disease: a pilot study
    Brian K Schilling
    Exercise Neuromechanics Laboratory, The University of Memphis, Memphis, TN 38152, USA
    Parkinsons Dis 2010:824734. 2010

Detail Information

Publications26

  1. ncbi Potential of transdermal drug delivery in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis 38163, USA
    Drugs Aging 19:561-70. 2002
    ..Techniques designed to enhance skin permeation and thus improve the effectiveness of transdermal drug delivery are also potential sources for future treatment advances...
  2. doi Autonomic dysfunction in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Memphis, TN 38163, USA
    Expert Rev Neurother 12:697-706. 2012
    ..Recognition of the various autonomic abnormalities of PD is important because effective treatment may be available and may measurably improve quality of life for individuals with PD...
  3. pmc High-throughput mutational analysis of TOR1A in primary dystonia
    Jianfeng Xiao
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA
    BMC Med Genet 10:24. 2009
    ..The aim of this study was to identify TOR1A Exon 5 mutations in a large cohort of subjects with mainly non-generalized primary dystonia...
  4. doi Neurologic presentations of gastrointestinal disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Memphis, TN 38163, USA
    Neurol Clin 28:75-87. 2010
    ..This article focuses on some of those disease processes. Illnesses primarily targeting the GI tract are addressed and examples of primary esophageal, gastric, and intestinal disease processes are described...
  5. doi Non-motor parkinsonism
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, TN, USA
    Parkinsonism Relat Disord 13:S211-20. 2007
    ..The early emergence of some non-motor features presents diagnostic opportunities, while the dopa-unresponsiveness of others poses treatment challenges, especially in the advanced stages of the disease...
  6. doi Wilson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA
    Handb Clin Neurol 100:681-709. 2011
    ..Appropriate diagnostic evaluations to confirm the diagnosis and institute treatment can be confusing. In this chapter, the clinical manifestations, diagnostic evaluation, and treatment approaches for Wilson's disease are discussed...
  7. doi Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
    Mov Disord 25:S94-7. 2010
    ..Both recognition and attention to appropriate treatment are important for optimum clinical management...
  8. ncbi Gastrointestinal dysfunction in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA
    Lancet Neurol 2:107-16. 2003
    ..Recognition of these gastrointestinal complications can lead to earlier and potentially more effective therapeutic intervention...
  9. doi Impaired leg extensor strength in individuals with Parkinson disease and relatedness to functional mobility
    Brian K Schilling
    Exercise Neuromechanics Laboratory, The University of Memphis, 314 Elma Neal Roane Fieldhouse, Memphis, TN 38152 3480, USA
    Parkinsonism Relat Disord 15:776-80. 2009
    ..Strength training of the lower extremity utilizing such multi-joint actions may be beneficial for this population...
  10. pmc Effects of moderate-volume, high-load lower-body resistance training on strength and function in persons with Parkinson's disease: a pilot study
    Brian K Schilling
    Exercise Neuromechanics Laboratory, The University of Memphis, Memphis, TN 38152, USA
    Parkinsons Dis 2010:824734. 2010
    ..05). No other significant interactions were noted (P > .05). Conclusions. Moderate volume, high-load weight training is effective for increasing lower-body strength in persons with PD...
  11. pmc Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients
    Ane Korff
    Department of Developmental Neurobiology, St Jude Children s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA
    Parkinsonism Relat Disord 17:765-8. 2011
    ..No changes were seen in other blood components. This suggests that GSTpi and potentially other members of this and other anti-oxidant families may be viable biomarkers for PD...
  12. doi Gastrointestinal dysfunction in Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Memphis, TN 38163, USA
    Parkinsonism Relat Disord 17:10-5. 2011
    ..The pathophysiologic basis for this dysfunction entails both central and enteric nervous system involvement...
  13. ncbi A promising new technology for Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Memphis, TN 38163, USA
    Neurology 65:S6-10. 2005
  14. doi Is α-synuclein rising to the surface as a diagnostic biomarker for Parkinson disease?
    William P Cheshire
    From the Department of Neurology W P C, Mayo Clinic, Jacksonville, FL and Department of Neurology R F P, University of Tennessee Health Science Center, Memphis
    Neurology 81:1568-9. 2013
    ....
  15. pmc Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study
    Elise Caccappolo
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    J Int Neuropsychol Soc 17:91-100. 2011
    ..Carriers of parkin mutations, whether or not they have PD, do not perform differently on neuropsychological measures as compared to noncarriers. The cognitive functioning of parkin carriers over time warrants further study...
  16. pmc Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease
    David K Simon
    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
    BMC Med Genet 11:53. 2010
    ..We investigated the potential contribution of mtDNA variants or mutations to the risk of PD...
  17. doi Parkinson disease. Nonmotor symptoms in Parkinson disease: the PRIAMO study
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Memphis, TN 38163, USA
    Nat Rev Neurol 5:531-2. 2009
    ..A multicenter survey of patients with Parkinson disease highlights the prevalence of these symptoms. The findings indicate that further research into the pathophysiology and treatment of nonmotor symptoms is warranted...
  18. ncbi Continued efficacy and safety of subcutaneous apomorphine in patients with advanced Parkinson's disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA
    Parkinsonism Relat Disord 13:93-100. 2007
    ..0001). Overall adverse event incidence did not significantly differ between pooled APO and pooled PL. This study supports the long-term use of intermittent APO as effective acute therapy for off episodes in advanced PD patients...
  19. ncbi Wilson's Disease
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
    Semin Neurol 27:123-32. 2007
    ..This article discusses the epidemiology, genetics, pathophysiology, clinical features, diagnostic testing, and treatment of Wilson's disease...
  20. doi Neurologic manifestations of malabsorption syndromes
    Ronald F Pfeiffer
    Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA Electronic address
    Handb Clin Neurol 120:621-32. 2014
    ..It is vitally important for neurologists to be aware of the potential for malabsorptive processes to produce neurologic dysfunction, because effective treatment for such disorders is often available. ..
  21. doi Effect of resistance training on blood oxidative stress in Parkinson disease
    Richard J Bloomer
    Department of Health and Sport Sciences, University of Memphis, Memphis, TN 38152, USA
    Med Sci Sports Exerc 40:1385-9. 2008
    ..Oxidative stress seems to be involved in the pathogenesis of Parkinson disease (PD). Exercise training can increase endogenous antioxidant protection and decrease the production of reactive oxygen and nitrogen species...
  22. pmc The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia
    Jianfeng Xiao
    Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
    Mov Disord 26:549-52. 2011
    ..Sequence variants in coding and noncoding regions of THAP1 have been associated with primary dystonia...
  23. ncbi Anticardiolipin antibody in vascular parkinsonism
    Zhigao Huang
    Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA
    Mov Disord 17:992-7. 2002
    ..Since the presence of ACLA in individuals with stroke is usually treated by full-scale anticoagulation with warfarin, our findings raise the question whether such treatment should also be used in persons with VP who are ACLA positive...
  24. ncbi A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease
    Paul A Nausieda
    Wisconsin Institute for Neurologic and Sleep Disorders, Regional Parkinson Center, Milwaukee, Wisconsin, USA
    Clin Ther 27:58-63. 2005
    ..In these patients, orally disintegrating tablets (ODTs) can be given without water and may provide greater convenience and ease of use than conventional tablets...
  25. pmc The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval
    Alexander Zimprich
    Hertie Institute for Clinical Brain Research, Department for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany
    Am J Hum Genet 74:11-9. 2004
    ..7 Mb). Our data provide evidence that the PARK8 locus is responsible for the disease in a subset of families of white ancestry with autosomal dominant parkinsonism, suggesting that it could be a more common locus...